My Trefis
Join Trefis today!
Register to create your own "My Trefis" of stocks, news, and people that interest you.
FILTER BY COMPANY
- All Companies
- Edit My Portfolio
-
Add to watch list:You don't have any companies in your watch list yet.
- My Collection
-
- Abbott Labs ABT
- Activision... ATVI
- Aeropostale ARO
- AMD AMD
- American Ea... AEO
- Apple AAPL
- Barrick Gol... ABX
- Boston Scie... BSX
- Chevron CVX
- China Telec... CHA
- ConocoPhill... COP
- Costco COST
- Electronic... EA
- Exxon Mobil XOM
- GameStop GME
- Google GOOG
- Home Depot HD
- Intel INTC
- Johnson & J... JNJ
- Jones Group JNY
- Medtronic MDT
- Microsoft MSFT
- nVIDIA NVDA
- Qualcomm QCOM
- Silver Whea... SLW
- Wal-Mart WMT
- Yahoo YHOO
You don't have any items in your collection. Click next to an item to add it to your collection.
BY CONTRIBUTOR
BY CONTENT
Example question: Bloomberg reported that supply constraints are leading to iPhone shortages. Do Trefis analysts see a meaningful impact on AAPL?
Example comment: Competition will squeeze AMZN's operating margins from 4% to 2% meaning a 10% hit to the stock according to Trefis.
Name (Required)
Email (Required, but never displayed)
SUBMITSUBMIT
Insert Chart or Image...
* Companies:
The math in this article is extremely poor and misleading to say the least. The Carotid Stent Costs quoted as $33,500 are exteremly exagerrated and in fact wrong. While this may be the procedural cost including fees for the hospital stay, consultants, surgeons, follow-up, etc..., the medical device manufacturers only sell the carotid stent. The $1 Billion windfall that the author suggests is revenue for the stent makers, is in fact far closer to $25 Million if the average selling price of carotid stents is $1000/device. Being +/- 50% or reality and the truth would be excusable. Exaggerating the revenue by 40 times is wreckless and inexcusable. It is a shame that TREFIS has idiots working for them.
[ less... ]
The math in this article is extremely poor and misleading to say the least. The Carotid Stent Costs quoted as $33,500 are exteremly exagerrated and in fact wrong. While this may be the procedural cost including fees for the hospital stay, consultants, surgeons, follow-up, etc..., the medical device manufacturers only sell the carotid stent. The $1 Billion windfall that the author suggests is revenue for the stent makers, is in fact far closer to $25 Million if the average selling price of carotid stents is $1000/device. Being +/- 50% or reality and the truth would be excusable. Exaggerating the revenue by 40 times is wreckless and inexcusable. It is a shame that TREFIS has idiots working for them.